Evidence map›Paper›PMID 42696130›Full record

ArticleEuropean archives of psychiatry and clinical neuroscience2026

Polygenic risk score for neurodevelopmental disorders and cognitive impairment at long-term follow-up of first-episode psychosis.

Manuel J Cuesta, Sergi Papiol, Gustavo J Gil-Berrozpe, Eloi Giné-Servén, Alejandro Ballesteros, David Peralta, Ana M Sánchez-Torres, Elena García de Jalón, Victor Peralta, SEGPEPs Group

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of psychiatry and clinical neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Manuel J CuestaDepartment of Psychiatry, Servicio de Psiquiatría, Hospital Universitario de Navarra, Pamplona, Spain. mcuestaz@navarra.es.ORCID https://orcid.org/0000-0003-0250-5718
Sergi PapiolNetwork Center for Biomedical Research in Mental Health (CIBER of Mental Health, CIBERSAM), Madrid, Spain.
Gustavo J Gil-BerrozpeDepartment of Psychiatry, Servicio de Psiquiatría, Hospital Universitario de Navarra, Pamplona, Spain.ORCID http://orcid.org/0000-0002-7509-9442
Eloi Giné-ServénDepartment of Psychiatry, Servicio de Psiquiatría, Hospital Universitario de Navarra, Pamplona, Spain.
Alejandro BallesterosInstituto de Investigación Sanitaria de Navarra (IdiSNA), C/ Irunlarrea, 3, 31008, Pamplona, Spain.
David PeraltaInstituto de Investigación Sanitaria de Navarra (IdiSNA), C/ Irunlarrea, 3, 31008, Pamplona, Spain.
Ana M Sánchez-TorresInstituto de Investigación Sanitaria de Navarra (IdiSNA), C/ Irunlarrea, 3, 31008, Pamplona, Spain.
Elena García de JalónInstituto de Investigación Sanitaria de Navarra (IdiSNA), C/ Irunlarrea, 3, 31008, Pamplona, Spain.
Victor PeraltaInstituto de Investigación Sanitaria de Navarra (IdiSNA), C/ Irunlarrea, 3, 31008, Pamplona, Spain.
SEGPEPs Group

Funding

Departamento de Salud, Gobierno de Navarra 17/31Departamento de Salud, Gobierno de Navarra 18/41Horizon 2020 Framework Programme 101057454Instituto de Salud Carlos III 15/02148Instituto de Salud Carlos III 19/01698Instituto de Salud Carlos III RD21/0009/0025
6 · The paper itself

Abstract

backgroundOne of the most outstanding contributions to the understanding of the etiopathogenesis of schizophrenia spectrum disorders (SSD) was the neurodevelopmental hypothesis. SSD and neurodevelopmental disorders (NDD) share pathogenetic mechanisms and overlapping clinical and cognitive impairment features.

methodsWe investigated whether polygenic risk scores (PRSs) for NDD are associated with cognitive performance in patients with first-episode psychosis (FEP). The sample comprised 127 patients with FEP who were followed up for a mean of 20.9 years. Cognitive examination was performed using the MoCA test at follow-up. Pearson coefficient correlations and multiple regression analyses were performed to examine the contribution of the three PRSs for rare neurodevelopmental conditions (PRS

resultsPRS

conclusionsThese results provide evidence for a possible direct genetic effect on cognitive performance for the PRS of common genetic variations related to neurodevelopment and attention deficit hyperactivity disorder in patients with FEP.

Indexed as

Cognitive impairmentFirst-episode psychosisLong-term outcomesNeurodevelopmental disordersPolygenic risk scoresSchizophrenia

Identifiers

PMID42696130

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.